---

Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡

---

Sarah Cannon Research Institute

🌎 scri.com

Sarah Cannon Research Institute (SCRI) is a leading oncology research organization that has been conducting community-based cancer clinical trials for over 30 years. With a focus on advancing therapies for patients, SCRI has conducted more than 800 first-in-human clinical trials and has a network of over 1,300 physicians across more than 250 locations in the U.S. The institute is known for its pivotal contributions to the development of new cancer therapies approved by the FDA.

---

Sarah Cannon Research Institute - Latest News and Updates

• Sarah Cannon Research Institute Oncology Partners in Nashville and Sarah Cannon Research Institute at HealthOne in Denver are involved in a novel population modelling-based strategy for first-in-human dose selection.
• Dee Anna Smith, CEO of Sarah Cannon Research Institute, moderated a panel discussion with McKesson and The US Oncology Network to improve patient access to oncology research in community settings.
• Sarah Cannon Research Institute is currently seeking a Head of Technology Delivery in the United States.
• Vivek Subbiah, MD, Chief of Early-Phase Drug Development at Sarah Cannon Research Institute, will be a Social Media Ambassador for the American Association for Cancer Research Annual Meeting.
• Sarah Cannon Research Institute is actively hiring for multiple remote and Nashville-based positions, including roles like Clinical Program Scientist and Oncology Research Nurse, as announced by Talent Advisor Abbey Phillips on April 28, 2025.

• Sarah Cannon Research Institute, in collaboration with Texas Oncology, is advancing testicular cancer research and care, as highlighted by Dr. Mike Lattanzi, Director of the Texas Oncology Genitourinary Cancer Research Program.
• Vivek Subbiah, Chief of Early-Phase Drug Development at Sarah Cannon Research Institute, expressed gratitude on LinkedIn after a patient gifted him zebra socks inspired by his ASCO educational book.

---

Sign up to receive regular updates

If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.